Keyword      Search in       

Contact
Imprint
Privacy Policy
Site Map

RSS Feed News. Your shopping cart.

Google gadget.

GMP News
09/11/2011
 

New QP Declaration for managing Expiry Dates of IMPs

  
In the recently published EMA Reflection paper on IVR/IWR systems, an additional QP Declaration is introduced for managing expiry dates. Overall the "Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials" seeks to provide guidance to Member States on what the expectations are on IVR/IWR systems and in particular on their use in expiry updating. In the case such a system is used to control expiry dates, a declaration by the Qualified Person (QP) is needed. This declaration should be part of both the Product Specification File (PSF) and Trial Master File. Annex 1 of the draft document shows what this declaration should look like.

In addition, the sponsor will need to notify the QP of the validation status of the IVR/IWR system (and any audit the sponsor has undertaken).

The end of consultation (deadline for comments) is 15 February 2012. Comments should be provided using this template. The completed comments form should be sent to gcp@ema.europa.eu.

Wolfgang Schmitt
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)

Related GMP News
16/05/2012Development and Manufacturing of APIs: Final ICH Q11 Document Published!
16/05/2012Which Information on Stability of Pharmaceutical Bulk Products is required in the Application Dossier?
16/05/2012EMA strengthens Oversight on Clinical Trials outside EU
16/05/2012EMA - Regulatory procedural Advice on similar biological medicines
09/05/2012The new EMA's eSubmission Gateway for Centralised Authorisations is released!